Nerve growth factor modulation of retinal ganglion cell physiology

Journal of Cellular Physiology

Volumn 229, Issue 9, 2014, Pages 1130-1133

  Roberti, Gloria ^a   Mantelli, Flavio ^a   Macchi, Ilaria ^b   Massaro Giordano, Mina ^c   Centofanti, Marco ^a,d  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; NERVE GROWTH FACTOR; PROTEIN BCL 2; PROTEIN TYROSINE KINASE A;

APOPTOSIS; AQUEOUS HUMOR; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; CHROMATIN; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; GLAUCOMA; HUMAN; INTERNALIZATION; INTRAOCULAR HYPERTENSION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RETINA GANGLION CELL; RETROGRADE NERVE FIBER TRANSPORT; UPREGULATION; VISUAL CORTEX;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; EYE DISEASES; GLAUCOMA; HUMANS; ISCHEMIA; NERVE GROWTH FACTOR; OCULAR HYPERTENSION; OPTIC NERVE INJURIES; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION;

EID: 84901218169     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24573     Document Type: Article

References (33)

1. Aloe L, Bracci-Laudiero L, Bonini S, Manni L. 1997. The expanding role of nerve growth factor: From neurotrophic activity to immunologic diseases. Allergy 52:883-894.
2. Ambati J, Canakis CS, Miller JW, Gragoudas ES, Edwards A, Weissgold DJ, Kim I, Delori FC, Adamis AP. 2000. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci 41:1181-1185.
3. Bjerre B, Bjorklund A, Stenevi V. 1973. Stimulation of growth of new axon sprouts from lesioned monoamine neurons in adult rat brain by nerve growth factor. Brain Res 60:161-176.
4. Bjerre B, Bjorklund A, Stenevi V. 1974. Inhibition of regenerative growth of central noradrenergic neurons by intracerebrally administered anti NGF-serum. Brain Res 74:1-18.
5. Bocchini V, Angeletti PU. 1969. The nerve growth factor: Purification as a 30, 000-molecular weight protein. Proc Natl Acad Sci USA 64:787-794.
6. Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L. 2000. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 107:1347-1351.
7. Carmignoto G, Maffei L, Candeo P, Canella R, Comelli C. 1989. Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J Neurosci 9:1263-1272.
8. Carmignoto G, Comelli MC, Candeo P, Cavicchioli L, Yan Q, Meringhi A, Maffei L. 1991. Expression of NGF receptor and NGF receptor mRNA in the developing and adult rat retina. Exp Neurol 111:302-311.
9. Chao MV, Rajagopal R, Lee FS. 2006. Neurotrophin signalling in health and disease. Clin Sci (Lond) 110:167-173.
10. Fahnestock M, Yu G, Coughlin MD. 2004. ProNGF: A neurotrophic or an apoptotic molecule? Prog Brain Res 146:101-110.
11. Ferrari MP, Mantelli F, Sacchetti M, Antonangeli MI, Cattani F, D'anniballe G, Sinigaglia F, Ruffini PA, Lambiase A. 2013. Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial. BioDrugs. [Epub ahead of print]
12. Friedman WJ, Greene LA. 1999. Neurotrophin signalling via Trks and p75. Exp Cell Res 253:131-142.
13. Huang EJ, Reichardt LF. 2003. TRK receptors: Roles in neuronal signal transduction. Annu Rev Biochem 72:609-642.
14. Johnson EM, Taniuchi M, Brent Clark H, Springer JE, Sookyong Koh, Tayrien MW, Loy R. 1987. Demonstration of the retrograde transport of nerve growth factor receptor in the peripheral and central nervous system. J Neurosci 7:923-929.
15. Kingman S. 2004. Glaucoma is second leading cause of blindness globally. Bull World Health Organ 82:887-888.
16. Klesse LJ, Parada LF. 1999. Trks: Signal transduction and intracellular pathways. Microsc Res Tech 45:210-216.
17. Koevary SB. 2003. Pharmacokinetics of topical ocular drug delivery: Potential uses for the treatment of diseases of the posterior segment and beyond. Curr Drug Metab 4:213-222.
18. Lambiase A, Centofanti M, Micera A, Manni GL, Mattei E, De Gregorio A, de Feo G, Bucci MG, Aloe L. 1997. Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes Arch Clin Exp Ophthalmol 235:780-785.
19. Lambiase A, Bonini S, Manni L, Ghinelli E, Tirassa P, Rama P, Aloe L. 2002. Intraocular production and release of nerve growth factor after iridectomy. Invest Ophthalmol Vis Sci. 43:2334-2340.
20. Lambiase A, Tirassa P, Micera A, Aloe L, Bonini S. 2005. Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Invest Ophthalmol Vis Sci 46:3800-3806.
21. Lambiase A, Pagani L, Di Fausto V, Sposato V, Coassin M, Bonini S, Aloe L. 2007. Nerve growth factor eye drop administrated in the ocular surface of rodents affects the nucleus basalis and septum; biochemical and structural evidence. Brain Res 1127:45-51.
22. Lambiase A, Aloe L, Centofanti M, Parisi V, Mantelli F, Colafrancesco V, Manni GL, Bucci MG, Bonini S, Levi-Montalcini R. 2009. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma. Proc Natl Acad Sci USA 32:13469-13475.
23. Levi-Montalcini R. 1987. The nerve growth factor: Thirty-five years later. Science 237:1154-1162.
24. Reichardt LF. 2006. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361:1545-1564.
25. Savilia S, Giuliani A, Fernández M, Turba ME, Forni M, Massella A, De Sordi N, Giardino L, Calzà L. 2009. Intravitreal NGF administration counteracts retina degeneration after permanent carotid artery occlusion in rat. BMC Neurosci 10:52.
26. Siliprandi R, Canella R, Carmignoto G. 1993. Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia. Invest Ophthalmol Vis Sci 34:3232-3245.
27. Sposato V, Parisi V, Manni L, Antonucci MT, Di Fausto V, Sornelli F, Aloe L. 2009. Glaucoma alters the expression of NGF and NGF receptors in visual cortex and geniculate nucleus of rats: Effects of eye NGF application. Vision Res 49:54-63.
28. Turner JE, Delaney RK. 1979. Retinal ganglion cell response to axotomy and nerve growth factor in the regenerating visual system of the newt (notophthalmus viridescens): An ultrastructural morphometric analysis. Brain Res 171:197-212.
29. Turner JE, Glaze KA. 1977. Regenerative repair in the severed optic nerve of the newt (triturus viridescens) effect of nerve growth factor. Exp Neurol 57:687-697.
30. Turner JE, Delaney RK, Powell R. 1978. Retinal ganglion cell response to axotomy in the regenerating visual system of the newt (triturus viridescens): An ultrastructural morphometric analysis. Exp Neurol 62:444-462.
31. Vantini G, Schiavo N, Di Martino A, Polato P, Triban C, Callegaro L, Toffano G, Leon A. 1989. Evidence for a physiological role of nerve growth factor in the central nervous system. Neuron 3:267-273.
32. Yan Q, Johnson EM, Jr. 1988. An immunohistochemical study of the nerve growth factor receptor in developing rats. J Neurosci 8:3481-3498.
33. Yan Q, Johnson EM, Jr. 1989. Immunoistochemical localization and biochemical characterization of nerve growth receptor in adult rat brain. J Comp Neurol 290:585-598.